Macrophage activating properties of the tryptophan catabolite picolinic acid

Advances in Experimental Medicine and Biology

Volumn 527, Issue , 2003, Pages 55-65

  Bosco, Maria Carla ^a   Rapisarda, Annamaria ^b   Reffo, Gioia ^b   Massazza, Stefano ^b   Pastorino, Sandra ^b   Varesio, Luigi ^b  

^a G GASLINI INSTITUTE   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; GAMMA INTERFERON; MACROPHAGE INFLAMMATORY PROTEIN; PICOLINIC ACID; TRYPTOPHAN;

ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; CONFERENCE PAPER; CYTOKINE PRODUCTION; EXPERIMENTAL MOUSE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE ACTIVATION; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; TRYPTOPHAN METABOLISM;

EID: 1042291141     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0135-0_6     Document Type: Conference Paper

References (71)

1. G. Melillo, M.C. Bosco, T. Musso, L. Varesio, Immunobiology of picolinic acid. In: Recent advances in tryptophan research, edited by G. Allegri Filippini, C.V.L. Costa, A. Bertazzo, (Plenum Press, New York, 1996), pp. 135-141.
2. W.T. Milton and F. Gensheng, Relationship between interferon-γ, indoleamine 2,3-dioxygenase, and tryptophan catabolism, FASEB J. 5, 2516-2522 (1991).
3. R.R. Brown, Y. Ozaki, S.P. Datta, E.C. Borden, P.M. Sondel, D.G. Malone, Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDS, Adv. Exp. Med. Biol. 294, 425-435 (1991).
4. L. Varesio, G. Cox, K. Pulkki, A. Brooks, G. Melillo, Arginine and tryptophan catabolism: the picolinic acid connection. In: Advances in tryptophan research, I. Ishiguro, R. Kido, T. Nagatsu, Y. Nagamura, Y. Ohta, Eds. (Fujita Health University Press, Tokyo, Japan, 1992), pp. 309-314.
5. W. Dai and S.L. Gupta, Molecular cloning, sequencing and expression of human interferon-γ-inducible indoleamine 2,3-dioxigenase cDNA, Biochem. Biophys. Res. Commun. 168, 1-9 (1990).
6. Y. Ozaki, M.P. Edelstein, D.S. Duch, Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon-gamma, Proc. Natl. Acad. Sci. USA 85, 1242-1249 (1988).
7. J.M. Carlin, E.C. Borden, G.I. Byrne, Interferon-induced indoleamine 2,3-dioxigenase activity inhibits Clamydia psittaci replication in human macrophages, J. Interferon Res. 9, 329-335 (1999).
8. E.R. Pfefferkom, Interferon-gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan, Proc. Natl. Acad. Sci. USA 81, 908-916 (1984).
9. T.F. Pais and R. Appelberg, Macrophage control of mycobacterial growth induced by picolinic acid is dependent on host cell apoptosis, J. Immunol. 164, 389-397 (2000).
10. H.W. Murray, A. Szuro-Sudol, D. Wellner, M.J. Oca, A.M. Granger, D.M. Libby, C.D. Rothermel, B.J. Rubin, Role of tryptophan degradation in respiratory burst-independent antimicrobial activity of gamma interferon- stimulated human macrophages, Infect. Immun. 57, 845-850 (1989).
11. L. Varesio, A. Soleti, D. Radzioch, K. Pulkki, A. Brooks, G.L. Gusella, M.C. Bosco, G. Forni, Picolinic acid and its influence on the immune system. In: L-tryptophan current prospects in medicine and drug safety., H. S. Walter Kochen, Ed. (Walter de Gruyter, Berlin, New York, 1994), pp. 99-110.
12. L. Varesio, I. Espinoza-Delgado, L. Gusella, G.W. Cox, G. Melillo, T. Musso, M.C. Bosco, Role of cytokines in the activation of monocytes. In: Human cytokines: their role in disease and therapy., B.B. Aggarwal and R.K. Puri, Eds. (Blackwell Scientific Publication, Inc., Cambridge, MA, 1995), pp. 55-69.
13. D.H. Munn, E. Shafizadeh, J.T. Attwood, I. Bondarev, A. Pashine, A.L. Mellor, Inhibition of T cell proliferation by macrophage tryptophan catabolism, J. Exp. Med. 189, 1363-1372 (1999).
14. K.M. Kopydlowski, C.A. Salkowski, M.J. Cody, N. Van Rooijen, J. Major, T.A. Hamilton, S.N. Vogel. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo, J. Immunol. 163, 1537-1544 (1999).
15. M.M. Shi, J.J. Godleski, J.D. Paulauskis. Regulation of macrophage inflammatory protein -1alpha mRNA by oxidative stress, J. Biol. Chem. 271, 5878-5883 (1996).
16. D.M. Paulnock, K.P. Demick, S.P. Coller. Analysis of interferon-gamma- dependent and-independent pathways of macrophage activation, J. Leukoc. Biol. 67, 677-682 (2000).
17. A. Mehler, Formation of picolinic and quinolinic acids following enzimatic oxidation of 3-hydroxyanthranilate to quinolate, J. Biol. Chem. 218, 241-250 (1956).
18. T. Rebello, B. Lonnerdal, L. Hurley, Picolinic acid in milk, pancreatic juice and intestine:inadequate for role in zinc absorpion, Am. J. Clin. Nutr. 35, 1-9 (1982).
19. G.W. Evans and P.E. Johnson, Characterization and quantitation of a zinc binding ligand in human milk, Pediatr. Res. 14, 867-871 (1980).
20. C. Dazzi, G. Candiano, S. Massazza, A. Ponzetto, L. Varesio, New high-performance liquid chromatografy method for the detection of picolinic acid in biological fluids, J. Chromatogr. B 751, 61-68 (2001).
21. L. Varesio, M. Clayton, E. Blasi, R. Ruffmann, D. Radzioch, Picolinic acid, a catabolite of L-tryptophan, as the second signal in the activation of IFN-gamma primed macrophages, J. Immunol. 145, 4265-4272 (1990).
22. G. Melillo, G. Cox, A. Biragyn, L. Sheffler, L. Varesio, Regulation of nitric oxide synthase mRNA expression by interferon-gamma and picolinic acid, J. Biol. Chem. 269, 8128-8135 (1994).
23. R. Ruffmann, R. Schlick, M. Chirigos, W. Budzynsky, L. Varesio, Antiproliferative activity of picolinic acid due to macrophage activation, Drugs. Exp. Clin. Res. 13, 607-611 (1987).
24. J. Fernandez-Pol, V. Bono, G. Johnson, Control of growth by picolinic acid: differential response of normal and transformed cells, Proc. Natl. Acad. Sci. USA 1, 2889-2895 (1977).
25. J. Plowman, S.D. Harrison, D. Dykes, K.D. Paull, V.L. Narayanan, H.K. Tobol, J. Martin, D.P. Griswold, Preclinical antitumor activity of an α-picoline derivate, penclomedine (NSC 388720), on human and murine tumors, Cancer Res 49, 1909-1915 (1989).
26. S.W. Leuthauser, L.W. Oberley, T.D. Oberley, Antitumor activity of picolinic acid in CBA/J mice, J. Natl. Cancer Inst 68, 123-129 (1982).
27. E. Blasi, R. Mazzolla, L. Pitzurra, R. Barluzzi, F. Bistoni, Protective effect of picolinic acid on mice intracerebrally infected with lethal doses of Candida albicans, Antimicrob. Agents Chemother 37, 2422-2426 (1993).
28. E. Blasi, D. Radzioch, L. Varesio, Inibition of retroviral mRNA expression in the murine macrophage cell line GG2EE by biologic response modifiers, J. Immunol. 141, 2153-2160(1988).
29. G. Melillo, T. Musso, A. Sica, L.S. Taylor, G. Cox, L. Varesio, A hypoxia responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter, J. Exp. Med. 182, 1683-1693 (1995).
30. G. Melillo, G. Cox, D. Radzioch, L. Varesio, Picolinic acid, a catabolite of L-tryptophan, is a costimulus for the induction of reactive nitrogen intermediate production in murine macrophages, J. Immunol. 150, 4031-4039 (1993).
31. C.F. Nathan and J.B. Hibbs, Role of nitric oxide synthesis in macrophage antimicrobial activity, Curr. Opin. Immunol. 3, 65-70 (1991).
32. T. Springer, Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm, Cell 76, 301-314 (1994).
33. A. Ben-Baruk, D. Michiel, J. Oppenheim, Signals and receptor involved in the recruitment of inflammatory cells, J. Biol. Chem. 270, 11703-11706 (1995).
34. M. Baggiolini, B. Dewald, B. Moser, Interleukin 8 and related chemotactic cytokines: CXC and CC chemokines, Adv. Immunol. 55, 97-179 (1994).
35. T. Schall, Biology of RANTES/SIS cytokine family, Cytokine 3, 165-183 (1991).
36. P. Murphy, Chemokine receptors: structure, functions and role in microbial pathogenesis, Cytokine Growth Factor Rev. 7, 47-53 (1996).
37. M. Miller and M. Krangel, Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines, Crit. Rev. Immunol. 12, 17-46 (1992).
38. D. Taub, T.J. Sayers, C.R.D. Carter, J. Ortaldo, α and β chemokines induce NK cell migration and enhance NK-mediated cytolysis, J. Immunol. 155, 3877-3888 (1995).
39. J.T. Siveke and A. Hamann, Cutting edge: T helper-1 and T helper-2 cells respond differentially to chemokines, J. Immunol. 160, 550-554 (1998).
40. M.R. Horton, M.D. Burdick, R. Strieter, C. Bao, P.W. Noble, Regulation of Hyaluronan-induced chemokine gene expression by IL-10 and IFN-gamma in mouse macrophages, J. Immunol. 160, 3023-3030 (1998).
41. M.C. Bosco, A. Rapisarda, S. Massazza, G. Melillo, H. Young, L. Varesio, The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage-inflammatory protein-1α and -1β in macrophages, J. Immunol. 164, 3283-3291 (2000).
42. W.J. Karpus, N.W. Lukacs, B.L. McRae, R. Strieter, S. Kunkel, S.D. Miller, An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis, J. Immunol. 155, 5003-5010 (1995).
43. F. Sallusto, A. Lanzavecchia, C.R. Mackay, Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses, Immunol. Today 19, 568-574 (1998).
44. + T cells in response to MIP-1α and MIP-1β, Science 260, 355-358 (1993).
45. L.A. DiPietro, M.D. Burdick, Q.E. Low, S. Kunkel, R. Strieter, MIP-1alpha as a critical macrophage chemoattractant in murine wound repair, J. Clin. Invest. 101, 1693-1698 (1998).
46. A. Rot, M. Krienger, T. Brunner, S. Bischoff, T. Shall, C. Dahinden, RANTES and macrophage protein 1α induce the migration and activation of normal human eosinophil granulocytes, J. Exp. Med. 176, 1489-1495 (1992).
47. D. Cook, The role of MIP-1 alpha in inflammation and hematopoiesis, J. Leukoc. Biol. 59, 61-66 (1996).
48. S. Schrum, P. Probst, B. Fleischer, P.F. Zipfel, Synthesis of the CC-chemokines MIP-1α, MIP-1β, and RANTES is associated with a type 1 immune response, J. Immunol. 157, 3598-3603 (1996).
49. D. Alberati-Giani, P. Malherbe, P. Ricciardi-Castagnoli, C. Kohler, S. Denis-Donini, A.M. Cesura, Differential regulation of indoleamine 2,3-dioxygenase expression by nitric oxide and inflammatory mediators in IFN-gamma-activated murine macrophages and microglial cells, J. Immunol. 159, 419-426 (1997).
50. J. Fernandez-Pol, Iron: possible cause of the G1 arrest induced by picolinic acid, Biochem Biophys Res Commun 78, 136-141 (1977).
51. G. Melillo, B. Taylor, A. Brooks, T. Musso, G. Cox, L. Varesio, Functional requirement of the hypoxia responsive element in the activation of the inducible nitric oxide synthase promoter by iron chelator desferrioxamine, J. Biol. Chem. 272, 12236-12243 (1996).
52. P. Giardina and R. Grady, Chelation therapy in beta-thalassemia: the benefits and limitation of desferrioxamine, Semin. Hematol. 32, 304-312 (1995).
53. N. Mukaida, Y. Mahe, K. Matsushima, Cooperative interaction of nuclear factor-κB- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by proinflammatory cytokines, J. Biol. Chem. 265, 21128-21133 (1990).
54. A.J. Valente, J. Xie, M. Abramova, U. Wenzel, H. Abbound, D. Graves. A complex element regulates IFN-gamma- stimulated monocyte chemoattractant protein-1 gene transcription. J. Immunol. 161, 3719-3728, 1998.
55. M. Baggiolini and C. Dahinden, CC chemokines in allergic inflammation, Immunol. Today 15, 127-133 (1994).
56. Z. Brown, R. Robson, J. Westwick, Regulation and expression of chemokines: potential role in glomerulonephritis, J. Leukocyte Biol. 59, 75-80 (1996).
57. M.J. Cameron, G.A. Arreaza, M. Grattan, C. Meagher, S. Sharif, M.D. Burdick, Strieter R, Cook D, T.L. Delovitch, Differential expression of CC-chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes, J. Immunol. 165, 1102-1110 (2000).
58. S. Gautam, J.M. Tebo, T. Hamilton, IL-4 suppresses cytokine gene expression induced by IFN-γ and/or IL-2 in murine peritoneal macrophages, J. Immunol. 148, 1725-1732 (1992).
59. C. Bogdan, Y. Vodovotz, C. Nathan, Macrophage deactivation by interleukin 10, J. Exp. Med. 174, 1549-1554 (1991).
60. Y. Ohmori and T. Hamilton, IFN-gamma selectively inhibits lipopolysaccharide-inducible JE/monocyte chemoattractant protein-1 and KC/GRO/melanoma growth-stimulating activity gene expression in mouse peritoneal macrophages, J. Immunol. 153, 2204-2212 (1994).
61. R. Bonecchi, S. Sozzani, J.T. Stine, W. Luini, G. D'Amico, P. Allavena, D. Chantry, A. Mantovani. Divergent effects of interleukin-4 and interferon-gamma on macrophage-derived chemokine (MDC) production: an amplification circuit of polarized T helper-2 responses, Blood 98, 2668-2671 (1998).
62. U. Boehm, T. Klamp, M. Groot, J. Howard, Cellular responses to interferon-gamma, Annu. Rev. Immunol. 15, 749-795 (1997).
63. Y. Ohmori and T. Hamilton, The interferon-stimulated response element and a κB site mediate synergistic induction of murine IP-10 gene transcription by IFN-γ and TNF-α, J. Immunol. 154, 5235-5239 (1995).
64. E. Blasi, D. Bauer, R. Barluzzi, R. Mazzolla, F. Bistoni, Pattern of cytokine gene expression in brains of mice protected by picolinic acid against lethal intracerebral infection with Candida albicans, J. Neuroimmunol. 52, 205-213 (1994).
65. W.J. Karpus and R. Ransohoff, Cutting edge commentary:chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis, J. Immunol. 161, 2667-2671 (1998).
66. A.E. Koch, S. Kunkel, L.A. Harlow, D.D. Mazarakis, G.K. Haines, M.D. Burdick, R.M. Pope, R. Strieter, Macrophage inflammatory protein-1alpha: a novel chemotactic cytokine for macrophages in rheumatoid arthritis, J. Clin. Invest. 93, 921-929 (1994).
67. + T cells. Science 270, 1811-1815, 1995.
68. G. Alkhatib, C. Combadiere, C.C. Broder, Y. Feng, P.E. Kennedy, P. Murphy, E.A. Berger. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272, 1955-1958, 1996.
69. H. Schmidtmayerova, S.L.H. Nottet, G. Nuovo, T. Raabe, C.R. Flanagan, L. Dubrovsky, H.E. Gendelman, A. Cerami, M. Bykrinsky, B. Sherry. Human immunodeficiency virus type 1 infection alters chemokine β peptide expression in human monocytes: implication for recruitment of leukocytes into brain and lymph nodes. Proc. Natl. Acad. Sci. USA 93, 700-709, 1996.
70. D. Fuchs, A. Forsman, L. Hagberg, M. Larsson, G. Norkrans, G. Reibnegger, E.R. Werner, H. Wachter. Immune activation and decreased tryptophan in patients with HIV-1 infection. J. Interferon Res. 10, 599-605, 1990.
71. C.L. Achim, M.P. Heyes, C.A. Wiley. Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brain. J. Clin. Invest. 91 , 2769-2775, 1993.